TOP2B antibody
Principal name
TOP2B antibody
Alternative names for TOP2B antibody
DNA topoisomerase 2-beta, DNA topoisomerase II beta isozyme
Ncbi ID
9606, NP_001059.2, NP_001059, AAI56331.1, NP_033435.2, NM_009409
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P), Immunocytochemistry/Immunofluorescence (ICC/IF)
Background of TOP2B antibody
TOP2B is a D topoisomerase, an enzyme that controls and alters the topologic states of D during transcription. This nuclear enzyme is involved in processes such as chromosome condensation, chromatid separation, and the relief of torsiol stress that occurs during D transcription and replication. It catalyzes the transient breaking and rejoining of two strands of duplex D which allows the strands to pass through one another, thus altering the topology of D. Two forms of this enzyme exist as likely products of a gene duplication event. The gene encoding this enzyme functions as the target for several anticancer agents and a variety of mutations in this gene have been associated with the development of drug resistance. Reduced activity of this enzyme may also play a role in ataxia-telangiectasia. This gene encodes a D topoisomerase, an enzyme that controls and alters the topologic states of D during transcription. This nuclear enzyme is involved in processes such as chromosome condensation, chromatid separation, and the relief of torsiol stress that occurs during D transcription and replication. It catalyzes the transient breaking and rejoining of two strands of duplex D which allows the strands to pass through one another, thus altering the topology of D. Two forms of this enzyme exist as likely products of a gene duplication event. The gene encoding this form, beta, is localized to chromosome 3 and the alpha form is localized to chromosome 17. The gene encoding this enzyme functions as the target for several anticancer agents and a variety of mutations in this gene have been associated with the development of drug resistance. Reduced activity of this enzyme may also play a role in ataxia-telangiectasia. Altertive splicing of this gene results in two transcript variants; however, the second variant has not yet been fully described. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additiol publications.












Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA310135 | TOP2B antibody |
||||||
| Rabbit anti-TOP2B polyclonal antibody | |||||||
![]() |
Rabbit | Purified | Hu | WB |
0.1 ml /
€220.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA314637 | TOP2B antibody |
||||||
| Rabbit polyclonal Topoisomerase II beta antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms | E, P, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
+2 additional images |
|||||||
| TA351833 | TOP2B antibody |
||||||
| Rabbit Polyclonal Anti-TOP2B Antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| AP06466PU-N | TOP2B antibody |
||||||
![]() |
Rabbit | Aff - Purified | Hu, Ms | P, WB |
0.1 mg /
€370.00
|
||
| OriGene Technologies GmbH | |||||||
+1 additional image |
|||||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR212050L2V | Lenti ORF particles, Top2b (GFP-tagged) - Mouse topoisomerase (DNA) II beta (Top2b), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€2,750.00
|
|
| OriGene Technologies, Inc. | ||
| MR212050L1V | Lenti ORF particles, Top2b (Myc-DDK-tagged) - Mouse topoisomerase (DNA) II beta (Top2b), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€2,480.00
|
|
| OriGene Technologies, Inc. | ||






+2 additional images

